Latest News on private equities market

Estonia warns of risks in wake of money laundering scandal

Estonia warns of risks in wake of money laundering scandal

Banks in Estonia have not yet plugged all the gaps in their money laundering controls, the Baltic state's regulator told Reuters, pledging to maintain a clampdown in the country at the center of one of Europe's biggest financial scandals.



7 years ago
Oil falls on demand concerns after gains on Mideast tensions

Oil falls on demand concerns after gains on Mideast tensions

Oil prices fell on Monday on concerns about the possibility of weakening demand after large gains last week caused tensions between the United States and Iran.



7 years ago
JetBlue sues Walmart for trademark infringement over Jetblack service

JetBlue sues Walmart for trademark infringement over Jetblack service

JetBlue Airways Corp has sued Walmart Inc for trademark infringement, after the world's largest retailer began using the name Jetblack for its text-based personal shopping service.



7 years ago

Bernie Sanders plans to cancel all $1.6 trillion of student debt by taxing Wall Street

Sen. Bernie Sanders will announce a plan on Monday to forgive the country's $1.6 trillion outstanding student loan tab.

7 years ago
Wall St. opens higher on tech boost

Wall St. opens higher on tech boost

U.S. stocks opened slightly higher on Monday, boosted by technology shares, while investors pinned their hopes on a meeting between Presidents Donald Trump and Xi Jinping later this week to de-escalate trade tensions.



7 years ago

Star analyst is getting pushback from clients on his negative GE takes but doesn't care

J.P. Morgan analyst Stephen Tusa is sticking to his guns when it comes to General Electric

7 years ago
Bristol-Myers plans to divest Celgene's psoriasis drug

Bristol-Myers plans to divest Celgene's psoriasis drug

Bristol-Myers Squibb Co on Monday offered to divest Celgene Corp's psoriasis treatment Otezla to allay concerns raised by the U.S. competition regulator, and pushed back the closing of their $74 billion deal.



7 years ago
G20 nerves hit Europe stocks; dollar slips to three-month low

G20 nerves hit Europe stocks; dollar slips to three-month low

European stocks stumbled and the dollar hit three-month lows on Monday as hopes waned for progress in Sino-U.S. trade talks at this week's G20 meeting and fears of an escalation in Iran tensions flared up.



7 years ago
New Companies for Week Ending 6/23/2019

New Companies for Week Ending 6/23/2019

New Companies for Week Ending 6/23/2019


The post New Companies for Week Ending 6/23/2019 appeared first on Crowditz.


7 years ago
Eldorado Resorts to buy Caesars Entertainment for about $8.5 billion

Eldorado Resorts to buy Caesars Entertainment for about $8.5 billion

Eldorado Resorts Inc has agreed to buy Caesars Entertainment Corp for about $8.5 billion in cash and stock, as it looks to build scale to take on competition from larger companies such as Las Vegas Sands and Wynn Resorts.



7 years ago
Futures edge higher with trade talks in focus

Futures edge higher with trade talks in focus

U.S. stock index futures edged higher on Monday, with investors hoping that the upcoming U.S.-China trade talks will help de-escalate a trade war that is damaging the global economy.



7 years ago

Handicapping the chances for a second-half rally in stocks

The major indexes have stretched to all-time highs and are riding one of their best first halves in decades.

7 years ago
FedEx confirms Huawei mail ban as new 'mistake' reignites Chinese ire

FedEx confirms Huawei mail ban as new 'mistake' reignites Chinese ire

FedEx Corp has apologized for another Huawei delivery "mistake", reigniting Chinese ire and drawing the fire of state media which suggested the U.S. delivery firm could end up on China's upcoming list of companies that harm national interests.



7 years ago

Investor Michael Farr: The market may have it wrong that major interest-rate cuts are coming

Is now the time to be reverting back to maximum monetary support?

7 years ago
Bristol to divest Celgene's psoriasis treatment in FTC clearance push

Bristol to divest Celgene's psoriasis treatment in FTC clearance push

Bristol-Myers Squibb Co said on Monday it would divest Celgene Corp's psoriasis treatment Otezla as the companies look to gain approval for their $74 billion deal from the U.S. Federal Trade Commission (FTC).



7 years ago